ABVC Biopharma Collaboration Between ABVC And Oncox Biopharma, ABVC Expecting Aggregate Income Of $13.75M And Royalties Of Up To $12.50M; Grants Oncox Exclusive Rights For One Of Abvc's Four Products In Its Oncology Pipeline To Develop, Manufacture,...
ABVC Biopharma Collaboration Between ABVC And Oncox Biopharma, ABVC Expecting Aggregate Income Of $13.75M And Royalties Of Up To $12.50M; Grants Oncox Exclusive Rights For One Of Abvc's Four Products In Its Oncology Pipeline To Develop, Manufacture,...
ABVC Biopharma与Oncox Biopharma之间的合作，ABVC预计总收入为1375万美元，特许权使用费高达1,250万美元；授予Oncox在其肿瘤学产品线中的四种产品之一的独家权利，用于开发、制造...
ABVC Biopharma Collaboration Between ABVC And Oncox Biopharma, ABVC Expecting Aggregate Income Of $13.75M And Royalties Of Up To $12.50M; Grants Oncox Exclusive Rights For One Of Abvc's Four Products In Its Oncology Pipeline To Develop, Manufacture, Commercialize Blex 404
ABVC Biopharma与Oncox Biopharma之间的合作，ABVC预计总收入为1375万美元，特许权使用费高达1,250万美元；授予Oncox对Abvc在其肿瘤学产品线中的四种产品之一的独家权利，用于开发、制造和商业化Blex 404
译文内容由第三方软件翻译。
以上内容仅用作资讯或教育之目的，不构成与富途相关的任何投资建议。富途竭力但不能保证上述全部内容的真实性、准确性和原创性。